Abstracts tagged "guidelines"

Abstract Number: 1325 • 2014 ACR/ARHP Annual Meeting
Single Hub and Access Point for Pediatric Rheumatology in Europe (SHARE): Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Localized Scleroderma and Juvenile Systemic Sclerosis
Bas Vastert¹, Roberta Culpo², Jordi Anton³, Tadej Avcin⁴, Eileen Baildam⁵, Christina Boros⁶, Tamás Constantin⁷, Jeff Chaitow⁸, Pavla Dolezalova⁹, Ozgur Kasapcopur¹⁰, Sheila Oliveira¹¹, Clarissa Pilkington¹², Annet van Royen-Kerkhof¹³, Ricardo A. G. Russo¹⁴, Claudia Saad-Magalhaes¹⁵, Natasa Toplak¹⁶, Angelo Ravelli¹⁷, Nico Wulffraat¹⁸, Ivan Foeldvari¹⁹ and Francesco Zulian²⁰, ¹University Medical Center Utrecht, Utrecht, Netherlands, ²Department of Pediatrics., University of Padua, Padua, Italy, ³Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, ⁴Pediatric Rheumatology, University Children´s Hospital, Ljubjana, Slovenia, ⁵Paediatric Rheumatology, Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, ⁶University of Adelaide, Adelaide, Australia, ⁷Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, ⁸The Children’s Hospital Westmead, Sydney, Australia, ⁹Department of Paediatrics and Adolescent Medicine, Charles University, Prague, Czech Republic, ¹⁰University Cerrahpasa Faculty of Medicine, Istanbul, Turkey, ¹¹Pediatric Rheumatology, Universidade F Rio De Janeiro, Rio De Janeiro, Brazil, ¹²Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ¹³Paediatric Immunology and Rheumatology, University Medical Centre Utrecht - Wilhelmina Children's Hospital, Utrecht, Netherlands, ¹⁴Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina, ¹⁵Faculdade de Medicina de Botucatu, Botucatu, Brazil, ¹⁶Pediatric Rheumatology, University Medical Center, Ljubliana, Slovenia, ¹⁷Istituto Giannina Gaslini and University of Genova, Genova, Italy, ¹⁸Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, ¹⁹Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, ²⁰Pediatrics/Rheumatology Div, University of Padua, Padua, Italy
Background/Purpose Juvenile Localized Scleroderma (JLS) and Juvenile Systemic Sclerosis (JSSc) form a group of rare pediatric diseases that can lead to significant morbidity. Evidence-based guidelines…
Abstract Number: 284 • 2014 ACR/ARHP Annual Meeting
Single Hub and Access Point for Paediatric Rheumatology in Europe (SHARE)– Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Idiopathic Arthritis
S.J. Vastert¹, Victor Boom², Jordi Anton³, Tamás Constantin⁴, Pavla Dolezalova⁵, Gerd Horneff⁶, Pekka Lahdenne⁷, Bo Magnusson⁸, Kirsten Minden⁹, K. Nistala¹⁰, Pierre Quartier¹¹, Ingrida Rumba-Rozenfelde¹², Nicolino Ruperto¹³, Vanessa Remy Piccolo¹⁴, Ricardo A. G. Russo¹⁵, Yosef Uziel¹⁶, Carine Wouters¹⁷, Alberto Martini¹⁸, Angelo Ravelli¹⁹, Helen Foster²⁰ and Nico Wulffraat²¹, ¹Pediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, ²Paediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, ³Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, ⁴Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, ⁵Paediatric Rheumatiology unit, 1st Faculty of Medicine, General University Hospital, Prague, Czech Republic, ⁶Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, ⁷Paediatrics, Helsinki University Central Hospital, Helsinki, Finland, ⁸Pediatric Rheumatology, Astrid Lindgren Children's Hospital, Stockholm, Sweden, ⁹Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ¹⁰Centre for Rheumatology, University College London, London, United Kingdom, ¹¹Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, ¹²University of Latvia, Riga, Latvia, ¹³Pediatria II,, Istituto Giannina Gaslini, Genoa, Italy, ¹⁴Pediatric Rheumatology, Hopital Necker Enfants Malades, Paris, France, ¹⁵Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina, ¹⁶Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, ¹⁷University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, ¹⁸Istituto Giannina Gaslini, Genova, Italy, ¹⁹University of Genova, Genova, Italy, ²⁰Newcastle University, Newcastle, United Kingdom, ²¹Paediatric Immunology and Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands
Background/Purpose Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic pediatric rheumatic diseases (PRD). As is the case for most PRD's, evidence-based guidelines…
Abstract Number: 2337 • 2013 ACR/ARHP Annual Meeting
Serious Adverse Events Associated With Using Biological Agents To Treat Rheumatic Diseases: Network Meta-Analysis From a National Guideline Panel
Simon Tarp¹, Ulrik Tarp², Lis S. Andersen³, Tove Lorenzen⁴, Hanne M. Lindegaard⁵, Michael Stoltenberg⁶, Hanne S. Jensen⁷, Birgitte Brock⁸, Camilla M. Mikkelsen⁹, Dorte V. Jensen¹⁰, Karsten Asmussen⁷, Troels Herlin¹¹ and Robin Christensen¹, ¹Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, ²Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, ³Department of Rheumatology, Copenhagen University Hospital, Gentofte, Denmark, ⁴Department of Rheumatology, Region Hospital Silkeborg, Silkeborg, Denmark, ⁵Department of Rheumatology, Odense University Hospital, Odense, Denmark, ⁶Department of Rheumatology, Copenhagen University Hospital, Køge, Denmark, ⁷Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, ⁸Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark, ⁹The Capital Region of Denmark Hospital Pharmacy, Medicine Information Centre, Copenhagen NV, Denmark, ¹⁰The Danish Rheumatologic Database (DANBIO), Center of Rheumatology and Spine Diseases VRR, Copenhagen University Hospital, Glostrup, Denmark, ¹¹Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Background/Purpose: Clinical guidelines are needed to help clinicians provide optimal medical treatment and advise patients about the potential hazards associated with certain drugs. Our objective…
Abstract Number: 1226 • 2013 ACR/ARHP Annual Meeting
Adherence With Current Osteoporosis Treatment Guidelines Among Rheumatologists Caring For Patients With Rheumatoid Arthritis Using Items From The Fracture Risk Assessment Tool Score
Jennifer Watt¹, Andrew E. Thompson², Nicole G. H. Le Riche³ and Janet E. Pope⁴, ¹Medicine, University of Western Ontario, London, ON, Canada, ²Rheumatology, St. Josephs Health Ctr, London, ON, Canada, ³Department of Medicine, St. Joseph's Hospital, London, ON, Canada, ⁴Medicine, Divsion of Rheumatology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Background/Purpose: To assess whether the Fracture Risk Assessment Tool (FRAX) score in patients with RA correlates with likelihood of osteoporosis (OP) prescription including drug treatment,…
Abstract Number: 1050 • 2013 ACR/ARHP Annual Meeting
Population-Based Analysis Of Treatment Patterns For Recently Diagnosed Rheumatoid Arthritis Patients In The United States
Martin M. Crane¹, Boyka Stoykova², Julie Priest¹, Nasha Wang¹, Henry Krzywy¹ and Rahul Ganguly³, ¹WW Epidemiology, GlaxoSmithKline, Durham, NC, ²Global Health Outcomes, GlaxoSmithKline, Uxbridge, United Kingdom, ³Global Health Outcomes, GlaxoSmithKline, Durham, NC
Background/Purpose: As treatment paradigms for rheumatoid arthritis (RA) continue to evolve, population-based studies can help assess which strategies are being used in “real-world” practice for…
Abstract Number: 103 • 2013 ACR/ARHP Annual Meeting
Proportion Of U.S. Older Adults Meeting Inclusion Criteria For 2010 ACR Recommendations On Glucocorticoid-Induced Osteoporosis
Robert A. Overman^1,2, Joshua C. Toliver³, Jun-Yen Yeh⁴, Margaret L. Gourlay⁵ and Chad L. Deal⁶, ¹Eshelman School of Pharmacy - Division of Pharmaceutical Policy and Outcomes, University of North Carolina, Chapel Hill, NC, ²Rheumatology, Cleveland Clinic, Cleveland, OH, ³Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, ⁴Arnold & Marie Schwartz College of Pharmacy and Health Sciences - Divison of Pharmaceutical Sciences, Long Island University, Brooklyn, NY, ⁵Family Medicine, University of North Carolina, Chapel Hill, NC, ⁶Dept of Rheum & Imm Dis /A 50, Cleveland Clinic, Cleveland, OH
Background/Purpose: Glucocorticoid-induced osteoporosis (GIO) is the most common cause of secondary osteoporosis. Fracture related to GIO increases a patient’s mortality risk and reduces quality of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].